(Outcome) Measure for (Intervention) Measures: A Guide to Choosing the Appropriate Noninvasive Clinical Outcome Measure for Intervention Studies in Celiac Disease

Gastroenterol Clin North Am. 2019 Mar;48(1):85-99. doi: 10.1016/j.gtc.2018.09.006. Epub 2018 Dec 13.

Abstract

There is an unmet need for diagnostic and treatment interventions for celiac disease. Both clinical trials and real-world studies require careful selection of clinical outcome measures. Often, neither serology nor histology is an appropriate primary outcome. This article reviews various measures of intestinal function and nutrition, patient-reported outcome measures for symptoms and for health-related quality of life, and measures of sickness burden as they apply to intervention studies for celiac disease. A series of case studies is presented to illustrate key considerations in selecting outcome measures for dietary interventions, pharmacologic interventions, and real-world studies.

Keywords: Celiac disease; Intervention studies; Outcome measures; Patient-reported outcomes; Study design.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Celiac Disease / diagnosis
  • Celiac Disease / therapy*
  • Cost of Illness
  • Diet Therapy
  • Diet, Gluten-Free
  • Humans
  • Oligopeptides / therapeutic use
  • Outcome Assessment, Health Care / methods*
  • Quality of Life
  • Treatment Outcome

Substances

  • Oligopeptides
  • larazotide acetate